US 9394234
Lipid formulations
granted A61KA61K31/22A61K31/7088
Quick answer
US patent 9394234 (Lipid formulations) held by ARBUTUS BIOPHARMA CORPORATION expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARBUTUS BIOPHARMA CORPORATION
- Grant date
- Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/22, A61K31/7088, A61K31/712, A61K31/713